ProCE Banner Activity

Managing Immune Thrombocytopenia: Latest Insights and a New Interactive Decision Support Tool

Clinical Thought

Read this expert commentary on current and investigational treatment options for ITP, which includes the introduction of an upcoming Interactive Decision Support Tool showing what experts would recommend for different clinical scenarios.

Released: October 18, 2022

Expiration: October 17, 2023

No longer available for credit.

Share

Faculty

Hanny Al-Samkari

Hanny Al-Samkari, MD

Assistant Professor
Harvard Medical School
Attending Hematologist and Clinical Investigator
Division of Hematology Oncology
Massachusetts General Hospital
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Novartis Pharmaceuticals Corporation

Rigel Pharmaceuticals Inc

Faculty Disclosure

Contributing Author

Hanny Al-Samkari, MD

Assistant Professor
Harvard Medical School
Attending Hematologist and Clinical Investigator
Division of Hematology Oncology
Massachusetts General Hospital
Boston, Massachusetts

Hanny Al-Samkari, MD: consultant/advisor/speaker: Agios, Argenx, Dova/Sobi, Forma, Moderna, Novartis, Rigel; researcher (paid to his institution): Agios, Amgen, Dova/Sobi.